{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T17:52:33Z","timestamp":1725904353293},"reference-count":46,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.8125","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T18:13:53Z","timestamp":1500056033000},"page":"1855-1861","source":"Crossref","is-referenced-by-count":3,"title":["Post-cytokine-release Salt Wasting as Inverse Tumor Lysis Syndrome in a Non-cerebral Natural Killer-cell Neoplasm"],"prefix":"10.2169","volume":"56","author":[{"given":"Hirotsugu","family":"Ariizumi","sequence":"first","affiliation":[{"name":"Department of Hematology, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Department of Pathology, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Hematology, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yui","family":"Uto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remi","family":"Azuma","sequence":"additional","affiliation":[{"name":"Department of Hematology, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohide","family":"Isobe","sequence":"additional","affiliation":[{"name":"Department of Pathology, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kishimoto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Shiozawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Takimoto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Ohike","sequence":"additional","affiliation":[{"name":"Department of Pathology, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiraku","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Hematology, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G. Epidemiology of metastatic brain tumors. Neurosurg Clin N Am 22: 1-6, 2011.","DOI":"10.1016\/j.nec.2010.08.007"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Teshima T, Akashi K, Shibuya T, et al. Central nervous system involvement in adult T-cell leukemia\/lymphoma. Cancer 65: 327-332, 1990.","DOI":"10.1002\/1097-0142(19900115)65:2<327::AID-CNCR2820650224>3.0.CO;2-W"},{"key":"3","unstructured":"3. Habu M, Tokimura H, Hirano H, et al. Pituitary metastases: current practice in Japan. J Neurosurg 123: 998-1007, 2015."},{"key":"4","unstructured":"4. Oh JY, Shin JI. Syndrome of inappropriate antidiuretic hormone secretion and cerebral\/renal salt wasting syndrome: similarities and differences. Front Pediatr 2: 146, 2015."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Maesaka JK, Imbriano LJ, Ali NM, Ilamathi E. Is it cerebral or renal salt wasting? Kidney Int 76: 934-938, 2009.","DOI":"10.1038\/ki.2009.263"},{"key":"6","unstructured":"6. Bitew S, Imbriano L, Miyawaki N, Fishbane S, Maesaka JK. More on renal salt wasting without cerebral disease: response to saline infusion. Clin J Am Soc Nephrol 4: 309-315, 2009."},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Berendes E, Walter M, Cullen P, et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 349: 245-249, 1997.","DOI":"10.1016\/S0140-6736(96)08093-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Momi J, Tang CM, Abcar AC, Kujubu DA, Sim JJ. Hyponatremia-what is cerebral salt wasting? Perm J 14: 62-65, 2010.","DOI":"10.7812\/TPP\/08-066"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Brunner-La Rocca HP, Kaye DM, Woods RL, Hastings J, Esler MD. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol 37: 1221-1227, 2001.","DOI":"10.1016\/S0735-1097(01)01172-X"},{"key":"10","unstructured":"10. Cerd\u00e0-Esteve M, Cuadrado-Godia E, Chillaron JJ, et al. Cerebral salt wasting syndrome: review. Eur J Intern Med 19: 249-254, 2008."},{"key":"11","unstructured":"11. Costa KN, Nakamura HM, Cruz LR, et al. Hyponatremia and brain injury: absence of alterations of serum brain natriuretic peptide and vasopressin. Arq Neuropsiquiatr 67: 1037-1044, 2009."},{"key":"12","unstructured":"12. Kojima J, Katayama Y, Moro N, Kawai H, Yoneko M, Mori T. Cerebral salt wasting in subarachnoid hemorrhage rats: model, mechanism, and tool. Life Sci 76: 2361-2370, 2005."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakayama S, Yokote T, Hirata Y, et al. TNF-\u03b1 expression in tumor cells as a novel prognostic marker for diffuse large B-cell lymphoma, not otherwise specified. Am J Surg Pathol 38: 228-234, 2014.","DOI":"10.1097\/PAS.0000000000000094"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ho CL, Sheu LF, Li CY. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma. Ann Diagn Pathol 7: 1-8, 2003.","DOI":"10.1053\/adpa.2003.50000"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Rupp W. Pharmacokinetics and pharmacodynamics of Lasix. Scott Med J 19 (Suppl 1): 5-13, 1974.","DOI":"10.1177\/00369330740190S103"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sch\u00fcck O. Fractional sodium excretion in patients with chronic renal failure with respect to the therapy. Nephron 30: 95-96, 1982.","DOI":"10.1159\/000182442"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Liddle GW. Clinical pharmacology of the anti-inflammatory steroids. Clin Pharmacol Ther 2: 615-635, 1961.","DOI":"10.1002\/cpt196125615"},{"key":"18","unstructured":"18. Travis RH, Sayers G. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs. In: Goodman &amp; Gilman&apos;s The Pharmacological Basis of Therapeutics. 3rd ed. Goodman LS, Gilman A, Eds. Macmillan, New York, 1966: 1608-1648."},{"key":"19","unstructured":"19. Forsham PH. The adrenals. In: Textbook of Endocrinology. 3rd ed. Williams RH, Ed. W.B. Saunders, Philadelphia, PA, 1962: 282-394."},{"key":"20","unstructured":"20. Himmerich H, Fulda S, Linseisen J, et al. TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur Cytokine Netw 17: 196-201, 2006."},{"key":"21","unstructured":"21. Wakefield LM, Letterio JJ, Chen T, et al. Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1: 129-136, 1995."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kamata Y, Kimura U, Matsuda H, et al. Relationships among plasma granzyme B level, pruritus and dermatitis in patients with atopic dermatitis. J Dermatol Sci 84: 266-271, 2016.","DOI":"10.1016\/j.jdermsci.2016.09.009"},{"key":"23","unstructured":"23. Engel P, Boumsell L, Balderas R, et al. CD Nomenclature 2015: Human Leukocyte Differentiation Antigen Workshops as a Driving Force in Immunology. J Immunol 195: 4555-4563, 2015."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sabbisetti VS, Waikar SS, Antoine DJ, et al. Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol 25: 2177-2186, 2014.","DOI":"10.1681\/ASN.2013070758"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273: 4135-4142, 1998.","DOI":"10.1074\/jbc.273.7.4135"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Kim HS, Kim HS, Lee CW, Chung DH. T cell Ig domain and mucin domain 1 engagement on invariant NKT cells in the presence of TCR stimulation enhances IL-4 production but inhibits IFN-gamma production. J Immunol 184: 4095-4106, 2010.","DOI":"10.4049\/jimmunol.0901991"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kishimoto W, Nishikori M, Arima H, et al. Expression of Tim-1 in primary CNS lymphoma. Cancer Med 5: 3235-3245, 2016.","DOI":"10.1002\/cam4.930"},{"key":"28","unstructured":"28. Verbalis JG. Hyponatremia with intracranial disease: not often cerebral salt wasting. J Clin Endocrinol Metab 99: 59-62, 2014."},{"key":"29","unstructured":"29. Cox P. Insensible water loss and its assessment in adult patients: a review. Acta Anaesthesiol Scand 31: 771-776, 1987."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ishikawa S, Saito T, Fukagawa A, et al. Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatremia in elderly subjects. J Clin Endocrinol Metab 86: 1665-1671, 2001.","DOI":"10.1210\/jc.86.4.1665"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Rubinow SI, Lebowitz JL. A mathematical model of the acute myeloblastic leukemic state in man. Biophys J 16: 897-910, 1976.","DOI":"10.1016\/S0006-3495(76)85740-2"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Prochazka V, Kubova Z, Raida L, Papajik T, Paucek B, Indrak K. Cerebral salt wasting syndrome in a patient with primary CNS lymphoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 153: 219-220, 2009.","DOI":"10.5507\/bp.2009.037"},{"key":"33","unstructured":"33. Jeon YJ, Lee HY, Jung IA, Cho WK, Cho B, Suh BK. Cerebral salt-wasting syndrome after hematopoietic stem cell transplantation in adolescents: 3 case reports. Ann Pediatr Endocrinol Metab 20: 220-225, 2015."},{"key":"34","unstructured":"34. Yuda S, Mori T, Kato J, et al. Sodium-losing nephropathy caused by tacrolimus after allogeneic hematopoietic stem cell transplantation. Rinsho Ketsueki (Jpn J Clin Hematol) 54: 2187-2191, 2013 (in Japanese, Abstract in English)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Gupta P, Bhatia V. Corticosteroid physiology and principles of therapy. Indian J Pediatr 75: 1039-1044, 2008.","DOI":"10.1007\/s12098-008-0208-1"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Park S, Ko YH. Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disorders. J Dermatol 41: 29-39, 2014.","DOI":"10.1111\/1346-8138.12322"},{"key":"37","unstructured":"37. Chuang HC, Lay JD, Hsieh WC, Su IJ. Pathogenesis and mechanism of disease progression from hemophagocytic lymphohistiocytosis to Epstein-Barr virus-associated T-cell lymphoma: nuclear factor-kappa B pathway as a potential therapeutic target. Cancer Sci 98: 1281-1287, 2007."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Mori A, Takao S, Pradutkanchana J, Kietthubthew S, Mitarnun W, Ishida T. High tumor necrosis factor-alpha levels in the patients with Epstein-Barr virus-associated peripheral T-cell proliferative disease\/lymphoma. Leuk Res 27: 493-498, 2003.","DOI":"10.1016\/S0145-2126(02)00266-7"},{"key":"39","unstructured":"39. Taguchi T. Phase I study of recombinant human tumor necrosis factor (rHu-TNF:PT-050). Cancer Detect Prev 12: 561-572, 1988."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Hamdi T, Latta S, Jallad B, Kheir F, Alhosaini MN, Patel A. Cisplatin-induced renal salt wasting syndrome. South Med J 103: 793-799, 2010.","DOI":"10.1097\/SMJ.0b013e3181e63682"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Seyberth HW. Pathophysiology and clinical presentations of salt-losing tubulopathies. Pediatr Nephrol 31: 407-418, 2016.","DOI":"10.1007\/s00467-015-3143-1"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Saleh M. Sepsis-associated renal salt wasting: how much is too much? BMJ Case Rep 2014. pii: bcr2013201838. doi: 10.1136\/bcr-2013-201838.","DOI":"10.1136\/bcr-2013-201838"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Adachi T, Arito M, Suematsu N, et al. Roles of layilin in TNF-\u03b1-induced epithelial-mesenchymal transformation of renal tubular epithelial cells. Biochem Biophys Res Commun 467: 63-69, 2015.","DOI":"10.1016\/j.bbrc.2015.09.121"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Cho E, Kim M, Ko YS, et al. Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model. Nephrol Dial Transplant 28: 2766-2778, 2013.","DOI":"10.1093\/ndt\/gft376"},{"key":"45","unstructured":"45. Hopkins SJ, McMahon CJ, Singh N, et al. Cerebrospinal fluid and plasma cytokines after subarachnoid haemorrhage: CSF interleukin-6 may be an early marker of infection. J Neuroinflammation 9: 255, 2012."},{"key":"46","unstructured":"46. Lee JH, Park DH, Back DB, et al. Comparison of cerebrospinal fluid biomarkers between idiopathic normal pressure hydrocephalus and subarachnoid hemorrhage-induced chronic hydrocephalus: a pilot study. Med Sci Monit 18: PR19-PR25, 2012."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/14\/56_56.8125\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T04:58:43Z","timestamp":1569819523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/14\/56_56.8125\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":46,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.8125","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}